Claritin and Rapaflo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Claritin (loratadine) and Rapaflo (silodosin). Common drug interactions include drug ineffective among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Claritin and Rapaflo. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Claritin?

Claritin has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 77,315 Claritin users. Check the latest studies of Claritin.

What is Rapaflo?

Rapaflo has active ingredients of silodosin. It is often used in prostate examination abnormal. eHealthMe is studying from 3,929 Rapaflo users. Check the latest studies of Rapaflo.

On Jul, 13, 2026

39 people who take Claritin and Rapaflo together, and have interactions are studied.

What are the common drug interactions of Claritin and Rapaflo, by gender? *:

female:

Drug ineffective
Suicidal ideation

male:

Fall
Drug ineffective
Leukocytosis (increased white blood cells)
Rib fracture
Somnolence (a state of near-sleep, a strong desire for sleep)
Affective disorder (mental disorder)
Chronic kidney disease
Concussion (short loss of normal brain function in response to a head injury)
Dizziness
Feeling hot

What are the common drug interactions of Claritin and Rapaflo, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Depression

30-39:

n/a

40-49:

Agitation (state of anxiety or nervous excitement)
Ammonia increased
Anger
Arterial thrombosis limb (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system-limb)
Emotional disorder
Onychomadesis (a periodic idiopathic shedding of the nails)
Skin discolouration (change of skin colour)
Drug ineffective
Affective disorder (mental disorder)
Depression

50-59:

n/a

60+:

Fatigue (feeling of tiredness)
Leukocytosis (increased white blood cells)
Renal failure (kidney dysfunction)
Renal injury (kidney injury)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Weight decreased
White blood cell count decreased
Drug effect delayed
Drug ineffective
Gait disturbance

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 25.64%
High Blood Pressure: 7 people, 17.95%
Back Pain: 5 people, 12.82%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 10.26%
Bladder Disorder: 4 people, 10.26%
Multiple Myeloma (cancer of the plasma cells): 4 people, 10.26%
Bladder Obstruction: 3 people, 7.69%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 3 people, 7.69%
Cardiac Failure: 2 people, 5.13%
Depression: 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Claritin and Rapaflo?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously